Ximei Resources Holding Limited (9936.HK)
Yingde, CN
Ximei Resources Holding Limited specializes in the manufacturing and global distribution of metallurgical products derived from tantalum and niobium. Its market reach extends across the People's Republic of China, the United States, Europe, and other international regions. The company's extensive product line encompasses oxides like tantalum pentoxide and niobium pentoxide, in addition to potassium heptafluorotantalate. It also supplies various forms of these metals, including tantalum powder, tantalum bars, niobium bars, niobium powders, and melted niobium, alongside recycled products such as tin hydroxide and tungsten acid. Furthermore, Ximei Resources provides valuable services, processing customer-supplied tantalum and niobium ores into pentoxide derivatives and potassium heptafluorotantalate. The company was founded in 2006 and is headquartered in Yingde, People's Republic of China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.29% | +4.84% | +26.64% | +28.68% | +218.72% | +206.46% | +462.71% | +536.42% | +308.20% | +881.28% | +881.28% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+23.0% ★ Q4'25: +67.1% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+37.1% ★ Q4'25: +83.3% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-7.9% Q4'25: -0.5% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+10.2% ★ Q4'25: +7.0% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+8.1% ★ Q4'25: +13.5% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+0.3% Q4'25: +0.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.91× Q4'25: 3.14× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
2.24B
est: 1.75B (+28.5%)
|
2.83B
2.35B – 3.31B
+62.4% YoY
|
3.11B
2.10B – 4.11B
+9.6% YoY
|
5.88B
4.89B – 6.88B
+89.3% YoY
|
| EBITDA |
258.39M
est: 250.91M (+3.0%)
|
407.56M
338.54M – 476.58M
+62.4% YoY
|
446.88M
302.18M – 591.58M
+9.6% YoY
|
845.96M
702.70M – 989.23M
+89.3% YoY
|
| EBIT |
227.92M
est: 213.78M (+6.6%)
|
347.25M
288.44M – 406.05M
+62.4% YoY
|
380.75M
257.46M – 504.04M
+9.6% YoY
|
720.78M
598.71M – 842.84M
+89.3% YoY
|
| Net Income |
171.60M
est: 171.60M (+0.0%)
|
398.00M
264.51M – 413.86M
+131.9% YoY
|
409.00M
385.43M – 603.05M
+2.8% YoY
|
795.00M
586.17M – 917.13M
+94.4% YoY
|
| SGA |
44.56M
est: 110.82M (-59.8%)
|
180.01M
149.53M – 210.49M
+62.4% YoY
|
197.38M
133.47M – 261.29M
+9.6% YoY
|
373.65M
310.37M – 436.92M
+89.3% YoY
|
| EPS |
0.48
est: 0.49 (-1.0%)
|
0.94
0.74 – 1.15
+94.4% YoY
|
1.37
1.07 – 1.68
+45.7% YoY
|
2.09
1.63 – 2.55
+52.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-28 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 26.7K | 0.39% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 16.0K | 0.28% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 4.3K | 0.29% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jieli Huang | Executive Director | 2M | female |
| Lijue Wu | Founder, Chairman of the Board & Chief Executive Officer | 1M | male |
| Zili Mao | Vice President & Executive Director | 271.6K | male |
| Eric Jackson Chang | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 9936.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
